Boston, MA -- (SBWIRE) -- 01/27/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Medical Marijuana Inc (OTCMKTS:MJNA), Promap Corp (OTCBB:CANN), MediSwipe Inc (OTCMKTS:MWIP), IntelGenx Technologies Corp. (OTCMKTS:IGXT)
Medical Marijuana Inc (OTCMKTS:MJNA) increased 24.19% at the price of $0.385 recently on a traded volume of 30.46 million shares, in comparison to 25.98 million shares of average trading volume. So far this year, the stock is up over 148.9%.
The company has a total market capitalization of $365.49 million and its total outstanding shares are 947.61 million. Medical Marijuana Inc. (MJNA) is the publicly held company vested in the medical marijuana and industrial hemp markets. It is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries.
For How Long MJNA will Fight for Profitability? Read This Trend Analysis report
Promap Corp (OTCBB:CANN) plunged -12.88% at the trading price of $15.22 on a traded volume of 140,729.00 shares till now, whereas its average trading volume is 133,313.00 shares. In the last three months, the stock is up 283.46%. The Intra-day range for the stock is $1.50 and $17.06. Promap Corporation develops, owns, and lease growing facilities to licensed marijuana growers and dispensary owners for their operations. The company was incorporated in 2013 and is based in Colorado Springs, Colorado.
Has CANN Found The Bottom And Ready To Gain Momentum? Find Out Here
MediSwipe Inc (OTCMKTS:MWIP) jumped up 6.23% at the $0.392 recently. So far in three months, the stock is up 1368.63%. The 52-week range for the stock is $0.08 and $1.27. Its introductory price for the day was $0.38, with the overall traded volume of 1.30 million shares. MediSwipe Inc., formerly Cannabis Medical Solutions Inc. offers a transaction processing and security solutions for the medical and healthcare industries, using traditional, Internet Point-of-Sale (POS), e-commerce and mobile (wireless) payment solutions.
Will MWIP Continue To Move Higher? Find Out Her
IntelGenx Technologies Corp. (OTCMKTS:IGXT) after opening its shares at the price of $1.06, jumped up 23.12% , its recent trading price was $0.979 for the day. The stock moved on a traded volume of 1.37 million shares, in comparison to 1.77 million shares of average trading volume.
The 52-week range for the stock is $0.45 and $1.09. Its introductory price for the day was $1.06. IntelGenx Technologies Corp. (IntelGenx) is a drug delivery company focusing on the development of orally administered drug delivery products based on its oral drug delivery technologies. The Company is a provider of product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets.
Why Should Investors Buy IGXT After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)